Ping Gu
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Ophthalmology top 1%
Papers in
-
- Retinal Development and Disorders 11
-
- Nanoplatforms for cancer theranostics 12
- Bone Tissue Engineering Materials 11
- Co-authors
- Xianqun Fan (36 shared papers)Jipeng Li (4 shared papers)Muyue Yang (3 shared papers)Huifang Zhou (18 shared papers)Zhimin Tang (11 shared papers)Yuan Deng (8 shared papers)Huiqin Gao (11 shared papers)Yahan Ju (14 shared papers)
- Journals
- Investigative Ophthalmology & Visual Science (4 papers)The Journal of Clinical Endocrinology & Metabolism (4 papers)Frontiers in Neurology (4 papers)Cell Death and Disease (3 papers)Advanced Healthcare Materials (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ping Gu
134 papers receiving 4.2k citations
Ping Gu's Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 603
- Ophthalmology 307
- Biomaterials 475
- Genetics 304
- Biomedical Engineering 964
Countries citing papers authored by Ping Gu
This map shows the geographic impact of Ping Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Gu more than expected).
Fields of papers citing papers by Ping Gu
This network shows the impact of papers produced by Ping Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Gu. The network helps show where Ping Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment Hit paper breakdown → | 2020 | 584 |
| 2 | HO-1-mediated ferroptosis as a target for protection against retinal pigment epithelium degeneration Hit paper breakdown → | 2021 | 257 |
| 3 | 2020 | 249 | |
| 4 | 2015 | 135 | |
| 5 | 2020 | 124 | |
| 6 | 2013 | 115 | |
| 7 | 2019 | 101 | |
| 8 | 2015 | 96 | |
| 9 | 2019 | 86 | |
| 10 | 2020 | 86 | |
| 11 | 2016 | 85 | |
| 12 | 2011 | 85 | |
| 13 | 2014 | 85 | |
| 14 | 2022 | 83 | |
| 15 | 2020 | 79 | |
| 16 | 2017 | 72 | |
| 17 | 2020 | 65 | |
| 18 | 2018 | 65 | |
| 19 | 2015 | 59 | |
| 20 | 2023 | 59 |
About Ping Gu
Ping Gu is a scholar working on Molecular Biology, Biomedical Engineering, Pulmonary and Respiratory Medicine, Ophthalmology and Cancer Research, having authored 144 papers that have together received 4.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (12 papers), Bone Tissue Engineering Materials (11 papers), Mesenchymal stem cell research (11 papers), Retinal Development and Disorders (11 papers), Retinal Diseases and Treatments (8 papers), MicroRNA in disease regulation (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Neurogenesis and neuroplasticity mechanisms (7 papers). The work is most often cited by research in Cancer Research (603 citations), Ophthalmology (307 citations), Biomaterials (475 citations), Genetics (304 citations) and Biomedical Engineering (964 citations). Ping Gu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xianqun Fan, Jipeng Li, Muyue Yang, Huifang Zhou, Zhimin Tang, Yuan Deng, Huiqin Gao, Yahan Ju, Dandan Zhang and Sijie Fang. Their work appears in journals such as Investigative Ophthalmology & Visual Science, The Journal of Clinical Endocrinology & Metabolism, Frontiers in Neurology, Cell Death and Disease and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.